N A Sheikh
Affiliation: Dendreon Corporation
- CD54 is a surrogate marker of antigen presenting cell activationN A Sheikh
Dendreon Corporation, 3005 1st Avenue, Seattle, WA 98121, USA
Cancer Immunol Immunother 57:1381-90. 2008..Thus these data support the use of CD54 upregulation as a surrogate for assessing human APC activation and validates its utility as a potency measure of sipuleucel-T...
- Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancerNadeem A Sheikh
Dendreon Corporation, Seattle, WA 98102 3703, USA
Cancer Immunol Immunother 62:137-47. 2013..Analysis of data from three phase 3 trials was performed to immunologically characterize this therapy during the course of the three doses, and to relate the immunological responses to overall survival (OS)...